- Home > Case Studies in HIV and HCV Coinfection: A STEP-HIV Initiative
Case Studies in HIV and HCV Coinfection: A STEP-HIV Initiative
Release date: January 19, 2017
Expiration date: January 19, 2018
Estimated time to complete: 1.0 hours
Activity URL: http://www.acthiv.org/webinar_HCV_Coinfection2.asp
Jointly Provided by:Support for this activity has been made possible through
educational grant from Gilead Sciences and ViiV Healthcare
This webinar is the latest in a series of Special Training for Effective Providers in HIV (STEP-HIV) initiatives developed by ACTHIV and the American Academy of CME, Inc. to promote HIV workforce development through education for healthcare professionals who are in training or who are in practice but are new to HIV medicine. It will focus on the approach to evaluation and management of patients with HIV/chronic HCV infection, beginning with a review of current epidemiologic data and management guidelines and offering guidance on how to implement them in practice.
Vincent Lo Re III, MD, MSCE
Assistant Professor of Medicine and Epidemiology, University of Pennsylvania
Senior Scholar, Penn Center for Clinical Epidemiology and Biostatistics
Co-Director, Penn Center for AIDS Research HIV/Viral Hepatitis Scientific Working Group
Vincent Lo Re III, MD, MSCE, is Assistant Professor of Medicine (Infectious Diseases) and Epidemiology at the University of Pennsylvania, Senior Scholar in the Penn Center for Clinical Epidemiology and Biostatistics, and Co-Director of the Penn Center for AIDS Research HIV/Viral Hepatitis Scientific Working Group. Dr. Lo Re leads a research program that examines the epidemiology of acute and chronic liver diseases in HIV-infected patients. He has conducted population-based and mechanistic studies that have helped to move the field of chronic viral hepatitis and HIV/viral hepatitis coinfection forward in a unique way. Recent research has evaluated end-stage liver disease and liver cancer events among HIV/hepatitis C-coinfected patients; examined how chronicviral hepatitis and HIV/viral hepatitis coinfection influence extra-hepatic outcomes, particularly metabolicbone disease; determined the impact that medications have on acute liver injury and progression of chronic viral hepatitis; and evaluated adherence and adverse effects of antiviral therapies of chronic hepatitis B and C. He has particular expertise in evaluating large electronic data sources, such as the Veterans Health Administration, Kaiser Permanente Northern California, US Medicaid, and US Medicare to evaluate liver-related and other health outcomes in viral hepatitis-infected patients. His research has been funded by the National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Agency for Healthcare Research and Quality, Department of Veterans Affairs, and the US Food and Drug Administration.He maintains an active clinical practice devoted to the care of patients with chronic viral hepatitis, particularly those coinfected with HIV. In addition to his clinical and research efforts, he is committed to fostering training in clinical research,teaching classes on HIV/viral hepatitis coinfection, biostatistics, infectious diseases epidemiology, gastrointestinal epidemiology, and patient-centered outcomes research.
- Review of current epidemiologic data for HIV/chronic HCV infection
- Management guidelines
- Guidance on how to implement guidelines in practice
- Drug-Drug interaction
This activity has been designed to meet the educational needs of physicians (both specialists and primary care/family medicine), advanced practice nurses, nurses, and physician assistants who are in training or who are in practice but are new to HIV medicine. Other healthcare providers may also participate.
After participating in the activity, learners should be better able to:
- Review the necessary evaluations for patients with HIV/HCV coinfection
- Recognize the impact of HIV suppression on liver outcomes
- Identify risk factors for HCV liver disease progression
- Review current HCV treatment options and their use in the HIV/HCV coinfected patient
- Consider antiretroviral-HCV drug-drug interactions when adding HCV therapy to the regimen of a coinfected patient
Accreditation and Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Academy of CME, Inc., (Academy) and ACTHIV. American Academy of CME, Inc., is accredited by the ACCME to provide continuing medical education for physicians.
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of CME, Inc, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
American Academy of CME, Inc., designates this educational activity for 1.0 contact hours (0.8 Pharmacotherapeutic Contact Hours).
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
Vin Lo Re III, MD, MSCE, discloses the following relationships: Grant/Research Support: AstraZeneca (not HCV/HIV related)
Sharon Lee, MD, Medical Director, Southwest Boulevard Family Health Care Services of Greater Kansas City, (Kansas); President, ACTHIV, discloses the following relationships: Advisory Board: Gilead Sciences, ViiV Healthcare
John JD Juchniewicz, MCIS, CHCP, and Natalie Kirkwood, RN, BSN, JD, Lead Nurse Planner, American Academy of CME, Inc.: No relevant financial relationships with any commercial interests.
This activity may contain discussion of off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy, ACTHIV or American Nurses Credentialing Center’s Commission on Accreditation. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Instructions on How to Receive Credit
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME/CNE credit for your participation, please complete the post-test (achieving a passing grade of 70%), and program evaluation. Your certificate will be available for printing immediately.
This program should be viewed at a resolution of 1024 x 768 or higher using current versions of Microsoft Internet Explorer, Firefox, Chrome or Safari. A high-speed Internet connection is recommended.
You must have the Adobe Flash Player installed on your computer in order to view this program. If you do not have the Adobe Flash Player, you can download this free plug-in from Adobe.com.
Privacy and Contact
© 2017. This CME/CNE-certified activity is held as copyrighted © by American Academy of CME and ACTHIV. Through this notice, the Academy and ACTHIV grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).